Abstract:In this study, a simple and sensitive UHPLC-ESI-MS/MS method was established for the determination of LXH254 in rat plasma. The developed method was validated according to the Food and Drug administration guidelines. After extraction using ethyl acetate, the sample was separated on an ACQUITY BEH C18 column. The mobile phase consisted of 2 mM ammonium acetate containing 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. The flow rate was 0.3 mL/min. A TSQ triple quadrupole mass spectrometer operated in positive-ion mode was used for mass detection, with multiple reaction monitoring transitions of m/z 503.3 > 459.1 and m/z 435.3 > 367.1 for LXH254 and olaparib (internal standard), respectively. An excellent linearity was achieved in the concentration range of 0.1-1000 ng/mL, with correlation coefficient >0.998. The mean recovery was more than 78.55%. Inter- and intra-day precision (percentage of relative standard deviation) did not exceed 12.87%, and accuracy was in the range of -2.50 to 13.50%. LXH254 was demonstrated to be stable under the tested storage conditions. The validated UHPLC-MS/MS method was further applied to the pharmacokinetic study of LXH254 in rat plasma after oral (2, 5, and 15 mg/kg) and intravenous (2 mg/kg) administrations. The pharmacokinetic study revealed that LXH254 showed low clearance, moderate bioavailability (~30%), and linear pharmacokinetic profile over the oral dose range of 2-15 mg/kg. To the best of our knowledge, this is the first report on the method development and validation of the determination of LXH254 and its application to pharmacokinetic study.

A rapid and sensitive LC-MS/MS assay for the determination of berbamine in rat plasma with application to preclinical pharmacokinetic study.

Determination of 4-Chloro-2-fluoro-3-methoxybenzeneboronic Acid in Rat Plasma by LC-MS/MS and Its Application in the Toxicokinetics Study

Simultaneous Determination of Capilliposide B and Capilliposide C in Rat Plasma by Lc-Ms/Ms and Its Application to A Pk Study

Development and Validation of a Highly Rapid and Sensitive LC–MS/MS Method for Determination of SZ-685C, an Investigational Marine Anticancer Agent, in Rat Plasma – Application to a Pharmacokinetic Study in Rats

Pharmacokinetic Study of 14-(3-methylbenzyl)matrine and 14-(4-methylbenzyl)matrine in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry.

A rapid and sensitive LC-MS/MS assay to quantify yonkenafil in rat plasma with application to preclinical pharmacokinetics studies.

A sensitive LC-MS/MS method to quantify loureirin B in rat plasma with application to preclinical pharmacokinetic studies.

Development and Validation of a Sensitive LC-MS-MS Assay for the Quantification of Betulonic Acid in Rat Plasma.

Development and validation of a highly sensitive UPLC–MS/MS method for the determination of Huperzine A in rat plasma

A validated LC-MS/MS method for the determination of RAF inhibitor LXH254: Application to pharmacokinetic study in rat

Development and Validation of an LC-MS/MS Method for the Determination of a Novel Thienoquinolin Urea Transporter Inhibitor PU-48 in Rat Plasma and Its Application to a Pharmacokinetic Study.

Development of a UPLC–MS/MS Method for Determination of Pimavanserin Tartrate in Rat Plasma: Application to a Pharmacokinetic Study

Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry: Assay Development, Validation and Application to A Human Pharmacokinetic Study

A Rugged and Accurate Liquid Chromatography–tandem Mass Spectrometry Method for Quantitative Determination of BMS-790052 in Plasma

A simple and sensitive LC-MS/MS method for the determination of sotalol in rat plasma.

Simultaneous Determination of 14-Thienyl Methylene Matrine and Matrine in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in A Pharmacokinetic Study

LC-MS/MS method for the simultaneous determination of icariin and its major metabolites in rat plasma.

Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method.

Development and validation of a rapid and sensitive assay for the determination of anisodamine in 50 μL of beagle dog plasma by LC-MS/MS.

Simultaneous determination of midazolam and 1'-hydroxymidazolam in rat plasma by protein precipitation and LC-MS: Application to pharmacokinetic study

Determination of Bis(9)-(-)-Meptazinol, a Bis-Ligand for Alzheimer's Disease, in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Application to Pharmacokinetics Study.